男性生殖遗传学的临床研究进展

范国庆, 高勇, 邓春华, 等. 男性生殖遗传学的临床研究进展[J]. 临床泌尿外科杂志, 2020, 35(12): 1000-1006. doi: 10.13201/j.issn.1001-1420.2020.12.014
引用本文: 范国庆, 高勇, 邓春华, 等. 男性生殖遗传学的临床研究进展[J]. 临床泌尿外科杂志, 2020, 35(12): 1000-1006. doi: 10.13201/j.issn.1001-1420.2020.12.014
FAN Guoqing, GAO Yong, DENG Chunhua, et al. Progress in clinical research of male infertility reproductive genetics[J]. J Clin Urol, 2020, 35(12): 1000-1006. doi: 10.13201/j.issn.1001-1420.2020.12.014
Citation: FAN Guoqing, GAO Yong, DENG Chunhua, et al. Progress in clinical research of male infertility reproductive genetics[J]. J Clin Urol, 2020, 35(12): 1000-1006. doi: 10.13201/j.issn.1001-1420.2020.12.014

男性生殖遗传学的临床研究进展

  • 基金项目:

    国家自然科学基金资助项目(No:81871110)

详细信息
    通讯作者: 高勇,E-mail:gyong@mail.sysu.edu.cn
  • 中图分类号: R697

Progress in clinical research of male infertility reproductive genetics

More Information
  • 男性生殖遗传学异常包括染色体、基因、精子DNA完整性及表观遗传学等多个方面,是导致男性不育的重要病因。随着基因测序技术的进步和辅助生殖技术的广泛应用,男性生殖遗传学已成为近年来的研究热点。本文对近年的男性生殖遗传学临床研究进行了分析和总结。重点探讨了3种常见的男性生殖遗传学疾病:克氏综合征、Y染色体微缺失和先天性输精管缺如。克氏综合征的流行病学现状、临床表现、治疗方法、手术取精成功率等;Y染色体微缺失的流行病学现状、各种分型的临床表现和治疗方法,重点探讨了Y染色体AZFc区缺失的不同治疗方式及妊娠结局;先天性输精管缺如患者的CFTR基因突变情况,及其对生育的影响及治疗策略。指出了目前研究的不足,展望了未来研究的方向。
  • 加载中
  • [1]

    Viuff MH,Stochholm K,Uldbjerg N,et al.Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for down syndrome[J].Hum Reprod,2015,30(10):2419-2426.

    [2]

    Zhang M,Fan HT,Zheng HS,et al.Clinical characteristics of men with non-mosaic klinefelter syndrome in northeastern China:implications for genetic counseling[J].Gen Mol Res,2015,14(3):10897-10904.

    [3]

    Chang S,Skakkebæk A,Trolle C,et al.Anthropometry in klinefelter syndrome--multifactorial influences due to cag length,testosterone treatment and possibly intrauterine hypogonadism[J].J Clin Endocrinol Metabol,2015,100(3):E508-E517.

    [4]

    Corona G,Pizzocaro A,Lanfranco F,et al.Sperm recovery and icsi outcomes in klinefelter syndrome:A systematic review and meta-analysis[J].Hum Reprod Update,2017,23(3):265-275.

    [5]

    Van Saen D,Vloeberghs V,Gies I,et al.When does germ cell loss and fibrosis occur in patients with klinefelter syndrome?[J].Hum Reprod,2018,33(6):1009-1022.

    [6]

    Nahata L,Yu RN,Paltiel HJ,et al.Sperm retrieval in adolescents and young adults with klinefelter syndrome:A prospective,pilot study[J].J Pediatr,2016,170:260-265.e261-262.

    [7]

    Franik S,Hoeijmakers Y,D'Hauwers K,et al.Klinefelter syndrome and fertility:Sperm preservation should not be offered to children with klinefelter syndrome[J].Hum Reprod,2016,31(9):1952-1959.

    [8]

    Plotton I,Giscard d'Estaing S,Cuzin B,et al.Preliminary results of a prospective study of testicular sperm extraction in young versus adult patients with nonmosaic 47,xxy klinefelter syndrome[J].J Clin Endocrinol Metabol,2015,100(3):961-967.

    [9]

    Eliveld J,van Wely M,Meiβner A,et al.The risk of tese-induced hypogonadism:A systematic review and meta-analysis[J].Hum Reprod Update,2018,24(4):442-454.

    [10]

    Flannigan R,Patel P,Paduch DA.Klinefelter syndrome.The effects of early androgen therapy on competence and behavioral phenotype[J].Sex Med Rev,2018,6(4):595-606.

    [11]

    Foland-Ross LC,Ross JL,Reiss AL.Androgen treatment effects on hippocampus structure in boys with klinefelter syndrome[J].Psychoneuroendocrinology,2019,100:223-228.

    [12]

    Davis SM,Lahlou N,Cox-Martin M,et al.Oxandrolone treatment results in an increased risk of gonadarche in prepubertal boys with klinefelter syndrome[J].J Clin Endocrinol Metab,2018,103(9):3449-3455.

    [13]

    Rohayem J,Nieschlag E,Zitzmann M,et al.Testicular function during puberty and young adulthood in patients with klinefelter's syndrome with and without spermatozoa in seminal fluid[J].Andrology,2016,4(6):1178-1186.

    [14]

    Fu L,Xiong DK,Ding XP,et al.Genetic screening for chromosomal abnormalities and y chromosome microdeletions in chinese infertile men[J].J Assist Reprod Gen,2012,29(6):521-527.

    [15]

    Krausz C,Hoefsloot L,Simoni M,et al.Eaa/emqn best practice guidelines for molecular diagnosis of y-chromosomal microdeletions:State-of-the-art 2013[J].Andrology,2014,2(1):5-19.

    [16]

    Johnson M,Raheem A,De Luca F,et al.An analysis of the frequency of y-chromosome microdeletions and the determination of a threshold sperm concentration for genetic testing in infertile men[J].BJU Int,2019,123(2):367-372.

    [17]

    Pan Y,Zhang HG,Xi QI,et al.Molecular microdeletion analysis of infertile men with karyotypic y chromosome abnormalities[J].J Intl Med Res,2018,46(1):307-315.

    [18]

    Tang D,Liu W,Li G,et al.Normal fertility with deletion of sy84 and sy86 in AZFa region[J].Andrology,2020,8(2):332-336.

    [19]

    Alksere B,Berzina D,Dudorova A,et al.Case of inherited partial azfa deletion without impact on male fertility[J].Case Rep Gen,2019,2019:3802613.

    [20]

    Zhu XB,Gong YH,He J,et al.Multicentre study of y chromosome microdeletions in 1,808 chinese infertile males using multiplex and real-time polymerase chain reaction[J].Andrologia,2017,49(5).

    [21]

    Franchim CS,Soares-Junior JM,Serafini PC,et al.Efficacy of mlpa for detection of y-chromosome microdeletions in infertile brazilian patients[J].J Assis Reprod Gen,2020,37(5):1251-1259.

    [22]

    Liu X,Li Z,Su Z,et al.Novel y-chromosomal microdeletions associated with non-obstructive azoospermia uncovered by high throughput sequencing of sequence-tagged sites[J].Scien Rep,2016,6:21831.

    [23]

    Schwarzer JU,Steinfatt H,Schleyer M,et al.Microdissection tese is superior to conventional tese in patients with nonobstructive azoospermia caused by y chromosome microdeletions[J].Andrologia,2016,48(4):402-405.

    [24]

    Chen X,Ma Y,Zou S,et al.Comparison and outcomes of nonobstructive azoospermia patients with different etiology undergoing microtese and icsi treatments[J].Tran And Urol,2019,8(4):366-373.

    [25]

    Zhang HL,Zhao LM,Mao JM,et al.Sperm retrieval rates and clinical outcomes for patients with different causes of azoospermia who undergo microdissection testicular sperm extraction-intracytoplasmic sperm injection[J].Asn J Androl,2020.

    [26]

    Abur U,Gunes S,Asci R,et al.Chromosomal and y-chromosome microdeletion analysis in 1,300 infertile males and the fertility outcome of patients with AZFc microdeletions[J].Andrologia,2019,51(11):e13402.

    [27]

    Corona G,Minhas S,Giwercman A,et al.Sperm recovery and icsi outcomes in men with non-obstructive azoospermia:A systematic review and meta-analysis[J].Hum Reprod Update,2019,25(6):733-757.

    [28]

    Colaco S,Modi D.Consequences of y chromosome microdeletions beyond male infertility[J].J Assist Reprod Gen,2019,36(7):1329-1337.

    [29]

    Xi Q,Zhang Z,Wang R,et al.Obstetric and perinatal outcomes of intracytoplasmic sperm injection for infertile men with y chromosome microdeletions[J].Medicine,2019,98(41):e17407.

    [30]

    Miraghazadeh A,Sadighi Gilani MA,Reihani-Sabet F,et al.Detection of partial azfc microdeletions in azoospermic infertile men is not informative of microtese outcome[J].Intl J Fertil Steril,2019,12(4):298-302.

    [31]

    Salvarci A,Gurbuz AS,Balasar M.Evaluation from a different perspective of 10-year results of infertile males with y chromosome AZFc microdeletions compared with a control group[J].Andrologia,2020,52(6):e13572.

    [32]

    Verón GL,Tissera AD,Bello R,et al.Impact of age,clinical conditions,and lifestyle on routine semen parameters and sperm kinematics[J].Fertil Steril,2018,110(1):68-75.e64.

    [33]

    Bieth E,Hamdi SM,Mieusset R.Genetics of the congenital absence of the vas deferens[J].Hum Gen,2020.

    [34]

    de Souza DAS,Faucz FR,Pereira-Ferrari L,et al.Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis:Reproductive implications and genetic counseling[J].Andrology,2018,6(1):127-135.

    [35]

    Wang H,An M,Liu Y,et al.Genetic diagnosis and sperm retrieval outcomes for chinese patients with congenital bilateral absence of vas deferens[J].Andrology,2020,8(5):1064-1069.

    [36]

    Yuan P,Liang ZK,Liang H,et al.Expanding the phenotypic and genetic spectrum of chinese patients with congenital absence of vas deferens bearing cftr and adgrg2 alleles[J].Andrology,2019,7(3):329-340.

    [37]

    Patat O,Pagin A,Siegfried A,et al.Truncating mutations in the adhesion g protein-coupled receptor g2 gene adgrg2 cause an x-linked congenital bilateral absence of vas deferens[J].Am J Hum Gen,2016,99(2):437-442.

    [38]

    Marson FAL,Bertuzzo CS,Ribeiro JD.Classification of cftr mutation classes[J].Lancet.Resp med,2016,4(8):e37-e38.

    [39]

    Yang B,Wang X,Zhang W,et al.Compound heterozygous mutations in cftr causing cbavd in chinese pedigrees[J].Mol Gen Gen Med,2018,6(6):1097-1103.

    [40]

    Lu S,Cui Y,Li X,et al.Association of cystic fibrosis transmembrane-conductance regulator gene mutation with negative outcome of intracytoplasmic sperm injection pregnancy in cases of congenital bilateral absence of vas deferens[J].Ferti Steril,2014,101(5):1255-1260.

    [41]

    Wu H,Gao Y,Ma C,et al.A novel hemizygous loss-of-function mutation in adgrg2 causes male infertility with congenital bilateral absence of the vas deferens[J].J Assist Reprod Gen,2020.

    [42]

    Eggers S,Sadedin S,van den Bergen JA,et al.Disorders of sex development:Insights from targeted gene sequencing of a large international patient cohort[J].Genome Biol,2016,17(1):243.

    [43]

    Kar B,Sivamani S,Kundavi S,et al.Complete androgen insensitivity syndrome in three generations of indian pedigree[J].J Obst Gyn India,2016,66(Suppl 1):358-362.

    [44]

    Xue LT,Wang RX,He B,et al.Effect of sperm DNA fragmentation on clinical outcomes for chinese couples undergoing in vitro fertilization or intracytoplasmic sperm injection[J].J Int Med Res,2016,44(6):1283-1291.

    [45]

    Sun TC,Zhang Y,Li HT,et al.Sperm DNA fragmentation index,as measured by sperm chromatin dispersion,might not predict assisted reproductive outcome[J].Taiwan J Obstet Gynecol,2018,57(4):493-498.

    [46]

    Cheung S,Parrella A,Rosenwaks Z,et al.Genetic and epigenetic profiling of the infertile male[J].PLoS One,2019,14(3):e0214275.

    [47]

    Carrell DT.The sperm epigenome:Implications for assisted reproductive technologies[J].Adv Exp Med Biol,2019,1166:47-56.

  • 加载中
计量
  • 文章访问数:  1096
  • PDF下载数:  863
  • 施引文献:  0
出版历程
收稿日期:  2020-06-21

目录